1-12 of 12
Kristina I. Rother
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes

Evgenia A. Gourgari, Mihriye Mete, Maureen L. Sampson, David M. Harlan, Alan T. Remaley, Kristina I. Rother
Journal: Diabetes Care
Diabetes Care 2017;40(7):e88–e89
https://doi.org/10.2337/dc16-2602
Published: 13 June 2017
View article titled, Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes
Open the PDF for Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes in another window
Journal Articles

Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670

Gayatri Sarkar, May Alattar, Rebecca J. Brown, Michael J. Quon, David M. Harlan, Kristina I. Rother
Journal: Diabetes Care
Diabetes Care 2014;37(10):e219–e220
https://doi.org/10.2337/dc14-1482
Published: 10 September 2014
View article titled, Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670
Open the PDF for Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670 in another window
Journal Articles

Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes

Gayatri Sarkar, May Alattar, Rebecca J. Brown, Michael J. Quon, David M. Harlan, Kristina I. Rother
Journal: Diabetes Care
Diabetes Care 2014;37(3):666–670
https://doi.org/10.2337/dc13-1473
Published: 11 February 2014
View article titled, Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes
Open the PDF for Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Novel Forms of Lipodystrophy: Why should we care?

Kristina I. Rother, MD, Rebecca J. Brown, MD
Journal: Diabetes Care
Diabetes Care 2013;36(8):2142–2145
https://doi.org/10.2337/dc13-0561
Published: 11 July 2013
View article titled, Novel Forms of Lipodystrophy: <subtitle>Why should we care?</subtitle>
Open the PDF for Novel Forms of Lipodystrophy: <subtitle>Why should we care?</subtitle> in another window
Journal Articles

Effects of Diet Soda on Gut Hormones in Youths With Diabetes

Rebecca J. Brown, MD, Mary Walter, PHD, Kristina I. Rother, MD
Journal: Diabetes Care
Diabetes Care 2012;35(5):959–964
https://doi.org/10.2337/dc11-2424
Published: 11 April 2012
View article titled, Effects of Diet Soda on Gut Hormones in Youths With Diabetes
Open the PDF for Effects of Diet Soda on Gut Hormones in Youths With Diabetes in another window
Journal Articles

Ingestion of Diet Soda Before a Glucose Load Augments Glucagon-Like Peptide-1 Secretion

Rebecca J. Brown, MD, Mary Walter, PHD, Kristina I. Rother, MD, MHSC
Journal: Diabetes Care
Diabetes Care 2009;32(12):2184–2186
https://doi.org/10.2337/dc09-1185
Published: 06 October 2009
View article titled, Ingestion of Diet Soda Before a Glucose Load Augments Glucagon-Like Peptide-1 Secretion
Open the PDF for Ingestion of Diet Soda Before a Glucose Load Augments Glucagon-Like Peptide-1 Secretion in another window
Journal Articles

Effects of Exenatide Alone and in Combination With Daclizumab on β-Cell Function in Long-Standing Type 1 Diabetes

Kristina I. Rother, MD, MHSC, Lisa M. Spain, PHD, Robert A. Wesley, PHD, Benigno J. Digon, III, MD, Alain Baron, MD, Kim Chen, PHD, Patric Nelson, MPH, H.-Michael Dosch, MD, Jerry P. Palmer, MD, Barbara Brooks-Worrell, PHD, Michael Ring, MD, David M. Harlan, MD
Journal: Diabetes Care
Diabetes Care 2009;32(12):2251–2257
https://doi.org/10.2337/dc09-0773
Published: 06 October 2009
View article titled, Effects of Exenatide Alone and in Combination With Daclizumab on β-Cell Function in Long-Standing Type 1 Diabetes
Open the PDF for Effects of Exenatide Alone and in Combination With Daclizumab on β-Cell Function in Long-Standing Type 1 Diabetes in another window
Journal Articles

Effect of Ingested Interferon-α on β-Cell Function in Children With New-Onset Type 1 Diabetes

Kristina I. Rother, MD, MHSC, Rebecca J. Brown, MD, Miriam M. Morales, BS, Elizabeth Wright, PHD, MPH, Zhigang Duan, MS, Carol Campbell, CRNP, Dana S. Hardin, MD, Jadranka Popovic, MD, Robert C. McEvoy, MD, David M. Harlan, MD, Philip R. Orlander, MD, Staley A. Brod, MD
Journal: Diabetes Care
Diabetes Care 2009;32(7):1250–1255
https://doi.org/10.2337/dc08-2029
Published: 01 July 2009
View article titled, Effect of Ingested Interferon-α on β-Cell Function in Children With New-Onset Type 1 Diabetes
Open the PDF for Effect of Ingested Interferon-α on β-Cell Function in Children With New-Onset Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Too Much Glucagon, Too Little Insulin: Time course of pancreatic islet dysfunction in new-onset type 1 diabetes

Rebecca J. Brown, MD, Ninet Sinaii, PHD, MPH, Kristina I. Rother, MD, MHSC
Journal: Diabetes Care
Diabetes Care 2008;31(7):1403–1404
https://doi.org/10.2337/dc08-0575
Published: 01 July 2008
View article titled, Too Much Glucagon, Too Little Insulin: <subtitle>Time course of pancreatic islet dysfunction in new-onset type 1 diabetes</subtitle>
Open the PDF for Too Much Glucagon, Too Little Insulin: <subtitle>Time course of pancreatic islet dysfunction in new-onset type 1 diabetes</subtitle> in another window
Journal Articles

Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression : Response to Charles and Selam

Boaz Hirshberg, MD, Kristina I. Rother, MD, Benigno J. Digon, III, MD, David M. Harlan, MD
Journal: Diabetes Care
Diabetes Care 2004;27(5):1250–1251
https://doi.org/10.2337/diacare.27.5.1250
Published: 01 May 2004
View article titled, Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression : <subtitle>Response to Charles and Selam</subtitle>
Open the PDF for Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression : <subtitle>Response to Charles and Selam</subtitle> in another window
Journal Articles

Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: The National Institutes of Health experience

Boaz Hirshberg, MD, Kristina I. Rother, MD, Benigno J. Digon, III, MD, Janet Lee, MD, Jason L. Gaglia, MD, Kenneth Hines, BS, MT (ASCP), Elizabeth J. Read, MD, Richard Chang, MD, Bradford J. Wood, MD, David M. Harlan, MD
Journal: Diabetes Care
Diabetes Care 2003;26(12):3288–3295
https://doi.org/10.2337/diacare.26.12.3288
Published: 01 December 2003
View article titled, Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: <subtitle>The National Institutes of Health experience </subtitle>
Open the PDF for Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: <subtitle>The National Institutes of Health experience </subtitle> in another window
Journal Articles

Sirolimus-Induced Interstitial Pneumonitis in an Islet Transplant Recipient

Benigno J. Digon, III, MD, Kristina I. Rother, MD, Boaz Hirshberg, MD, David M. Harlan, MD
Journal: Diabetes Care
Diabetes Care 2003;26(11):3191
https://doi.org/10.2337/diacare.26.11.3191
Published: 01 November 2003
View article titled, Sirolimus-Induced Interstitial Pneumonitis in an Islet Transplant Recipient
Open the PDF for Sirolimus-Induced Interstitial Pneumonitis in an Islet Transplant Recipient in another window